April 26, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of an inter-disciplinary infectious disease engagement with a top 10 global biopharmaceutical company.
The biopharmaceutical company, part of a select group of global leaders in drug development for the treatment of infectious diseases, approached Thought Leader Select for support with its development pipeline across the Canadian market. To meet the combined strategic needs of the company’s emerging pipeline in treating conditions like HIV and Hepatitis-C, Thought Leader Select will deploy its in-house research group for a multi-disciplinary assessment of the key opinion leader community in infectious diseases.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following areas:
For the first wave of the assessment, the Thought Leader Select research group will identify 50 physicians appropriate for compliant engagement in support of drug development for infectious diseases, across multiple Canadian provinces.
In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought leaders, including basic and clinical research, scientific journal publishing, speaking at medical meetings, and crafting treatment guidelines.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships, and a suite of tools to promote collaborative work with KOLs, including engagement plans and an online scenario-planning portal.
In addition, Thought Leader Select’s consulting team will deliver analysis and recommendations based on the company’s understanding of the geographic impact of each key opinion leader at global, national, and regional levels, as well as detailed professional network mapping that shows pockets of collaboration among leading doctors across geographies and specialty areas.
“Working in the area of infectious disease is highly rewarding, since we know that our work will ultimately benefit millions of patients by having the leading doctors work on new treatments,” stated Kristen Smithwick, Vice President of Business Development, Marketing, and Strategic Planning at Thought Leader Select. “We are appreciative that this client gave us a great opportunity to deliver multiple offerings across our company skill set—consulting, KOL identification, profiling, and mapping by our research team, as well as a collection of great tools to support their development strategies.”
About Thought Leader Select
Thought Leader Select is a Chapel Hill, NC-based private consulting firm serving the biopharmaceutical, medical device, and diagnostics industries with strategies, in-house research, and a suite of engagement tools and support for collaborating with and reaching out to key opinion leaders and centers of excellence in medicine.
Thought Leader Select has supported companies as they develop effective treatments to promote better patient and public health across more than 18 therapeutic areas and 50 diseases and conditions. Thought Leader Select’s customized work strengthens medical marketing initiatives, medical affairs outreach, and payer marketing strategies to support market access, pricing, and reimbursement issues.
Brian Castle, Director of Global Marketing and Client Relations